logo
IVD Medical Holding Limited (01931.HK): Officially launched the application for the US stablecoin license and accelerated the landing of the IVDNewCo Exchange ecosystem

IVD Medical Holding Limited (01931.HK): Officially launched the application for the US stablecoin license and accelerated the landing of the IVDNewCo Exchange ecosystem

Malay Mail4 days ago
HONG KONG SAR - Media OutReach Newswire - 21 July 2025 – IVD Medical Holding Limited(01931.HK) - Forward-looking layout of the historical opportunity of the US "Genius Act", the IVDD stablecoin plan is gathering momentum to set sail and build a new global infrastructure for medical innovative drugs RWA!In the wave of deep integration of global digital finance and medical innovation, IVD Medical Holding Limited(01931.HK) took the lead in building the "NewCo+RWA" Web3 exchange ecosystem (IVDNewCo Exchange) with the construction of medical innovative drugs high-tech assets as the core and the supporting stablecoin "IVDDollar" (IVDD) plan as the core strategy, leading the digital revolution of global medical innovation assets.On July 20, 2025, the Board of Directors is pleased to announce that the US subsidiary carrying the Group's aforementioned core strategic mission has landed, and the IVDNewCo Exchange ecosystem has officially landed on the international financial stage. The company released the latest announcement today, officially announcing two milestones: the US wholly-owned subsidiary IVD GROUP INC. has completed registration, and the Group has officially started the process of submitting a stablecoin license application to the US regulator through the subsidiary; at the same time, the Web3 exchange ecosystem with medical innovative drug NewCo assets as the core - IVDNewCo Exchange and its supporting stablecoin IVDD have entered a substantive stage.This strategic move not only marks the Group's leading position in the field of compliant digital finance for medical innovative drugs, but also heralds a revolutionary breakthrough in the global medical asset liquidity and value conversion model.On July 18, 2025, local time, US President Trump signed the "Guidance and Establishment of the United States Stablecoin National Innovation Act" (hereinafter referred to as the "Genius Act") at the White House, establishing the legal status of stablecoins as "digital dollars". The implementation of this bill, together with the Stablecoin Ordinance of the Hong Kong Special Administrative Region, which will take effect on August 1, forms a regulatory synergy between the East and the West, and jointly builds the compliance cornerstone of the global stablecoin market.The report of the China Banking Research Institute pointed out that currently 99% of the world's stablecoins are anchored to US dollar assets, and US Treasury bonds have become the core choice of stablecoin reserve assets due to their low risk and high liquidity. In this context, the Group proactively laid out the application for the US stablecoin license, and on July 20 officially announced that the US subsidiary had initiated the process of submitting application materials to regulatory agencies such as the US SEC and CFTC, becoming one of the very few listed companies in the Hong Kong stock market that has completed the "Hong Kong + US" dual hub compliance architecture layout.The strategic layout of the Group is deeply in line with the global regulatory trend. By establishing the US subsidiary IVD GROUP INC., we not only meet the strict requirements of the "Genius Act" for 100% reserve asset coverage and independent auditing of stablecoin issuers, but also rely on the sandbox mechanism of the Hong Kong "Stablecoin Ordinance" to build a cross-regional regulatory endorsement system. This dual hub model provides the IVDNewCo Exchange ecosystem with globally rare compliant liquidity support, enabling the Group to establish a first-mover advantage in the "Hong Kong Stock Stablecoin Concept Sector".The core breakthrough of the IVDNewCo Exchange ecosystem lies in the deep integration of Web3 technology and medical innovative drug assets. Relying on the commercial network covering 1,674 tertiary hospitals in China and the ability to acquire high-quality NewCo assets around the world, the Group has created the world's first RWA (real world asset) tokenization platform focusing on medical innovative drugs. The platform achieves the following innovations through blockchain technology:1). Asset tokenization: converting innovative drug assets such as ADC drugs, bi-antibody therapy, and cell gene therapy in the clinical stage into tradable and divisible digital certificates to break through the liquidity bottleneck of traditional medical assets;2). Compliance financial infrastructure: establish an underlying architecture to support the issuance, trading and settlement of IVDD stablecoins, ensuring that each $1 stablecoin corresponds to ultra-short-term U.S. Treasury bonds and other low-risk assets, meeting the U.S. SEC's "1:1 redeemable" requirements;3). Coin-stock linkage mechanism: coordinate with Nasdaq's dual primary listing plan to explore the compound value creation model of "digital assets + traditional equity" to attract two-way inflows of traditional medical capital and crypto-native funds.The implementation of this technical architecture has been strongly supported by industry data. Public information shows that the current global innovative drug market has exceeded US$1.2 trillion, and China accounts for 6% of the market with a scale of RMB 450 billion, with an annual compound growth rate of 20.3%. Through the RWA platform, the Group expects to significantly improve the financing efficiency of innovative drug assets, while lowering the entry threshold for investors, allowing small and medium-sized investors around the world to participate in the medical innovation field that was originally limited to institutional investment.The Group's strategic advancement has always followed the three-dimensional path of "regulatory compliance-technological innovation-ecological synergy". In the United States, IVD GROUP INC.'s license application strictly follows the requirements of the Genius Act for reserve asset transparency, anti-money laundering (AML) and network security. Its technical system has passed a third-party security audit to ensure that smart contracts are free of loopholes; in Hong Kong, the Group will actively promote participation in the HKMA's stablecoin sandbox program to test reserve asset management and cross-border payment scenarios, laying the foundation for license application.More importantly, the implementation of the IVDNewCo Exchange ecosystem is reshaping the value chain of innovative medical drugs. Under the traditional model, the research and development of innovative drugs requires a cycle of up to 10 years, and 80% of the funds are concentrated in the clinical stage. Through the RWA platform, the Group can monetize clinical-stage assets in advance, provide pharmaceutical companies with low-cost financing channels, and provide investors with dynamic returns linked to the progress of drug development. For example, an ADC drug in Phase II clinical trials can attract global capital participation through tokenization, and its development progress data will be uploaded to the chain in real time to ensure that investors' rights and interests are transparent and traceable.The Group's strategic initiatives have attracted widespread attention from the capital market and the industry. After the announcement on the 17th, IVD Medical's share price opened sharply higher on the 18th, closing at HK$2.95, up 20.41% throughout the day, with a turnover exceeding HK$9.4886 million and a market value of HK$4.783 billion. Behind the market data is investors' strong confidence in the cross-border integration of "NewCo+RWA+stablecoin".Looking ahead, the Group will continue to deepen the three strategic directions of compliance expansion, technology deepening and ecological integration. Against the backdrop of the global low interest rate environment and the surge in demand for medical innovation, it will use Web3 technology as a bridge to connect traditional medical capital and digital financial innovation. We firmly believe that through compliance layout and technological innovation, the IVDNewCo Exchange ecosystem will become a value amplifier for global innovative medical drug assets, creating a win-win situation for patients, pharmaceutical companies and investors.Hashtag: #IVDMedicalHoldingLimited
The issuer is solely responsible for the content of this announcement.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

OSL Group Secures US$300 Million in Equity Financing to Accelerate Global Digital Asset Infrastructure Expansion
OSL Group Secures US$300 Million in Equity Financing to Accelerate Global Digital Asset Infrastructure Expansion

Malaysian Reserve

time6 hours ago

  • Malaysian Reserve

OSL Group Secures US$300 Million in Equity Financing to Accelerate Global Digital Asset Infrastructure Expansion

HONG KONG, July 25, 2025 /PRNewswire/ — OSL Group ( Asia's leading regulated digital asset platform, today announced the successful completion of a US$300 million equity financing round — the largest publicly disclosed equity raise in Asia's digital asset sector to date. This landmark financing underscores strong market confidence in OSL's digital asset business model and long-term growth trajectory, while laying a solid foundation for the Group's next phase of international expansion. The capital will be allocated across three core areas: Supporting the Group's strategic acquisition initiatives – continuing its aggressive global expansion drive, with strategic combinations of potential licensing, acquisitions, partnerships and transactions. Developing new global businesses initiatives, including payment and stablecoin initiatives – accelerating OSL's build-out of global business and payment networks, integrating fiat currencies, stablecoins, and major digital assets. This infrastructure is designed to provide institutional and enterprise clients with secure, efficient, and seamless cross-border payment solutions. Further strengthening its working capital – giving OSL even more competitive advantage, not just in terms of reach and coverage, but also in scale and volume. Since initiating its expansion strategy in late 2023, OSL has executed several transformative acquisitions and advanced its regulatory footprint across major digital asset jurisdictions. The Group has also received growing recognition from capital markets, with its market capitalization exceeding HK$10 billion this year — a clear signal of investor confidence in its regulated digital asset platform and scalable international strategy. Ivan Wong, Chief Financial Officer of OSL Group, commented: 'This US$300 million equity raise marks a major milestone in our journey and reflects strong conviction in OSL's digital asset strategy and execution. The funding will accelerate our global buildout — particularly in regulated payment infrastructure and access points. As a pioneer in regulated digital assets, OSL is committed to shaping the next chapter of global finance with trust, innovation, and institutional-grade infrastructure.' As Hong Kong's first listed and licensed digital asset trading platform, OSL remains committed to advancing the regulated evolution of the digital asset industry. This financing round further cements its leadership role as a key enabler of Web3 infrastructure across the Asia-Pacific region. About OSL Group OSL Group (HKEX: is a leading global financial infrastructure platform bridging traditional finance and the digital asset economy through blockchain technology. The Group is dedicated to providing efficient, seamless, and regulatory-compliant financial services to individuals and businesses worldwide. OSL delivers a comprehensive suite of regulated services through its licensed platforms, including 24/7 OTC brokerage with deep liquidity fiat gateways and competitive pricing; omnibus brokerage solutions enabling traditional financial institutions to integrate digital assets; SOC 2 Type 2-certified custody with up to US$1 billion insurance protection; and compliant retail trading channels; wealth management solutions, including scheduled launches on tokenised treasuries and RWAs; and in preparation for cross-border payment infrastructure via OSL Pay. 'Open, Secure, Licensed' are the principles OSL lives by. OSL is expanding its compliant infrastructure across Japan, Australia, and Europe, potentially Southeast Asia, powering the next generation of global financial infrastructure. Logo – View original content:

The CMA: Compensation for Investors Affected by Violations Committed in the Shares of 'Watani Iron Steel Co.'
The CMA: Compensation for Investors Affected by Violations Committed in the Shares of 'Watani Iron Steel Co.'

Barnama

time9 hours ago

  • Barnama

The CMA: Compensation for Investors Affected by Violations Committed in the Shares of 'Watani Iron Steel Co.'

RIYADH, Saudi Arabia, July 25 (Bernama) -- The Capital Market Authority (CMA) announces the completion of compensation for investors affected by the violations committed in the shares of Watani Iron Steel Co., which occurred before and after the company's direct listing on the Parallel Market (Nomu). These violations were committed by five individuals convicted under the decision issued by the Appeal Committee for Resolution of Securities Disputes (ACRSD), published on the websites of the CMA and the GS-CRSD on April 4, 2024. The decision, resulting from the penal lawsuit filed by the Public Prosecution and referred by the Capital Market Authority, obligated them to pay SAR 41.4 million in illegal gains resulting from these violations. The compensations were deposited into the accounts of the affected investors through the Compensation Fund, which was established pursuant to a resolution of the CMA's Board to compensate affected parties in accordance with the distribution plan approved by the CRSD. This facilitates the compensation process and ensures that entitlements are delivered to their rightful owners with minimal effort.

Wall Street futures mixed as investors weigh Alphabet, Tesla earnings
Wall Street futures mixed as investors weigh Alphabet, Tesla earnings

Free Malaysia Today

timea day ago

  • Free Malaysia Today

Wall Street futures mixed as investors weigh Alphabet, Tesla earnings

The S&P 500 and Nasdaq surged to fresh records as reports of a trade deal between the EU and the US boosted risk sentiment. (EPA Images pic) NEW YORK : US stock index futures were mixed today as investors assessed earnings from Alphabet and Tesla while focusing on progress in trade deals between the US and its top partners. Google-parent Alphabet raised its capital spending plans for the year to about US$85 billion and predicted a further increase next year, shrugging off uncertainties from US trade policy. Its shares rose 3.5% premarket. Electric carmaker Tesla, however, painted a gloomy picture, with CEO Elon Musk warning that reduced government support for EV makers could lead to a 'few rough quarters' for the company. Its stock dropped 5%. By 5.57am, S&P 500 E-minis were up 7.75 points, or 0.12%, and Nasdaq 100 E-minis were up 85.25 points, or 0.37%. Dow E-minis were down 136 points, or 0.3%. The blue-chip yesterday came just shy of surpassing its all-time highs touched in December. The benchmark S&P 500 and the tech-heavy Nasdaq surged to fresh records as reports of an imminent trade deal between the EU and the US boosted risk sentiment. Diplomats said the deal would result in 15% import tariffs on the bloc. Additionally, President Donald Trump's announcement of a deal with Japan has also aided investor sentiment this week. The pact includes slashing tariffs on goods from the Asian country to 15%. With the Aug 1 deadline just a week away, investors expect a flurry of more trade negotiations, given that China and South Korea are also seeking deals to avoid Trump's hefty duties. Amid escalating tensions between the Trump administration and the Federal Reserve (Fed), the president will visit the central bank later in the day. Trump has been persistently attacking Fed chair Jerome Powell for not cutting rates and mused publicly about firing him. The central bank holds its monetary policy meeting next week, with markets widely expecting policymakers to leave interest rates unchanged. Traders see a 62.2% likelihood of a cut in September, according to the CME Group's FedWatch tool. Later in the day, investors will parse weekly jobless claims and S&P Global's flash PMI data to examine the health of the economy amid tariff uncertainties. Among other earnings-related moves, IBM slid 5.25% as its second-quarter earnings failed to impress investors, especially due to its lower-than-expected sales in its mainstay software segment. Shares of ServiceNow jumped 7.1% after the software firm raised its annual subscription revenue forecast.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store